Integra LifeSciences falls on quarterly revenue miss, downbeat Q1 forecast

Integra LifeSciences Holdings

25/02/2025 12:47

** Shares of Integra LifeSciences  IART.O  fall 4.8% to $21
premarket
    ** Life sciences firm posts Q4 revenue of $442.6 million,
missing analyst est of $445.1 million, as per data compiled by
LSEG 
    ** Co reports Q4 adj profit of 97 cents/share vs analyst est
of 86 cents/share
    ** IART forecasts 2025 revenue in the range of $1.65 bln to
$1.71 bln
    ** Analysts, on average, were expecting revenue to be $1.71
bln for 2025 
    ** Co says it expects Q1 revenue in the range of $375 mln to
$385 mln, lower than analyst est. of $410.2 mln
     ** IART forecasts Q1 profit in the range of $0.40/share to
$0.45/share
    ** Stock has fallen 50.7% in the last 12 months 
 

 (Reporting by Padmanabhan Ananthan)
 ((Padmanabhan.Ananthan@thomsonreuters.com;))